Covid-19 news

22 May 2020

The Center for Genomic Regulation (CRG), the National Center for Genomic Analysis (CNAG-CRG), part of CRG, the Institute for Research in Biomedicine (IRB Barcelona) and the Institute for Bioengineering of Catalonia (IBEC) have analysed more than 20,000 samples to date using the PCR technique. In this regard, 17,547 samples have been tested at the CRG node and 5,248 at the PCB node.

The analyses are part of the Orfeu Programme, the mass screening initiative driven by the Government of Catalonia. As of today, the public health system in Catalonia can carry out up to 17,000 PCR tests every day. This number does not include the capacity of the Orfeu Programme, which can process up to...

19 May 2020

The Chemical Checker provides processed, harmonized and ready-to-use bioactivity information on more than 1M small molecules

The tool, developed by the Structural Bioinformatics and Network Biology lab at IRB Barcelona, has been published in Nature Biotechnology.

 

11 May 2020

The global pandemic that we are living poses a major challenge for society at all levels. In these moments of uncertainty, IRB Barcelona has put what it knows best, cutting-edge research, at the service of the public.

IRB Barcelona’s efforts are focused on two lines of action. The first is participation in the mass PCR-based screening initiative of the Orfeu Programme, driven by  the Government of Catalonia, in collaboration with the research centres CRG, IBEC and CNAG.

The second line of action is the research...

9 Apr 2020

Several media have reported on the platform set up by IRB Barcelona, the Center for Genomic Regulation (CRG) and the Institute for Bioengineering of Catalonia (IBEC) for mass testing for  COVID-19, which seeks to contribute to halting the spread of the virus. In this regard, the labs at IRB Barcelona will conduct sample analysis to detect infected individuals during lockdown and also when confinement measures are progressively relaxed. 

The director of IRB Barcelona, Francesc Posas, has expressed his satisfaction at being able to adapt the activity of his centre to support society at a time when mass detection is crucial for controlling the spread of the virus...

7 Apr 2020

The Centre for Genomic Regulation (CRG) is coordinating a task force with the Institute for Research in Biomedicine (IRB Barcelona) and the Institute for Bioengineering of Catalonia (IBEC), as requested by Generalitat de Catalunya, to set up mass testing for citizens to stop the spread of the new coronavirus outbreak.

There will be two mass testing sites – one coordinated by the CRG at its labs at the Barcelona Biomedical Research Park (PRBB) and another at the Parc Cientific de Barcelona, jointly coordinated by IRB Barcelona, IBEC and the Centro Nacional de Análisis Genómico (CNAG-CRG), part of the CRG.

The project, codenamed Programa Orfeu by the Generalitat de Catalunya...

<p>Nostrum BioDiscovery team</p>
7 Apr 2020

Several media have reported on the collaboration of Nostrum Biodiscovery, a company cofounded by IRB Barcelona researcher Modesto Orozco, with Grifols and IrsiCaixa. This spin-off company from IRB Barcelona will contribute to research into COVID-19 by providing data that will facilitate the intelligent design of drugs in silico for the treatment of coronavirus.

The company has issued a press release to announce this collaboration and the appointment of its new CEO, Ezequiel Mas del Molino. Nostrum Biodiscovery thus begins a new period marked by an ambitious growth plan in which it will strengthen its present in the European and US markets.

Link to:...

6 Apr 2020

At the end of February 2020, the media were reporting alarming news that warned of the magnitude of the tragedy that was about to occur in China as a result of the spread of the SARS-CoV-2 epidemic. Back then, it seemed a long way off, an outbreak that perhaps could be contained. However, emergencies of different types, magnitude and scope were gradually activated across the globe until the very images we had witnessed elsewhere took hold in Spain at great speed, shaking the foundations of our society and daily lives. The last four weeks have transformed the capacity of people, services and society as a whole to operate and adapt. IRB Barcelona’s mission is to respond to...

3 Apr 2020

·       The tool is based on Chemical Checker technology, developed by the Structural Bioinformatics and Network Biology Laboratory at IRB Barcelona.

·       The aim is to use artificial intelligence to generate a drug database that includes all the published scientific results related to the treatment of COVID-19.

·       This open access database will provide researchers from around the world with an expanded portfolio of molecules with the potential to fight COVID-19.

30 Mar 2020

Several media have published an interview with Patrick Aloy, head of the Structural Bioinformatics and Network Biology Lab at IRB Barcelona, in which he talks about a study being done by scientists at the University of California. This study analyses the physical interactions of the coronavirus in order to understand how this virus “sequesters” our proteins to ensure its survival. This research aims to find drugs that can act against these proteins. In this regard, the researchers at the University of California have found 70 compounds, including around 30 drugs authorized by the US Food and Drug Agency(FDA).

Aloy explains that the strategy to look for pharmacological targets...

24 Mar 2020

A personal chronicle by Tanya Yates

The outbreak of COVID-19 is dramatically changing the way we live and work.  Following the recommendations made by the Spanish Ministry of Health to mitigate the spread of the disease, IRB Barcelona is one of the many companies that has embraced working from home or telework. So,for those of us whose jobs allow this flexibility, we now spend 8 hours a day in front of a pc at home. Great work everyone! But after our working day has ended, we are challenged by social lockdown, which implies that we should leave our homes only to buy food and medicine and receive medical treatment. Strangely, on day one of lockdown, in Spain you...